PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Royal recognition for university’s dementia work

Newcastle University has won the UK’s highest national honor for universities in recognition of work transforming the understanding, diagnosis and care of people with dementia with Lewy bodies

2025-11-25
(Press-News.org) Newcastle University has won the UK’s highest national honour for universities in recognition of work transforming the understanding, diagnosis and care of people with Dementia with Lewy bodies.

The prestigious Queen Elizabeth Prizes for Higher and Further Education are awarded by the monarch every two years in recognition of world-class excellence and achievement at academic institutions. Newcastle University has been recognised with a Queen Elizabeth Prize for Education in this round and the last one in 2023, for excellence in water research.

Dementia with Lewy bodies (DLB)

Dementia with Lewy bodies (DLB) is the second most common form of dementia after Alzheimer’s disease, affecting an estimated 130,000 people in the United Kingdom and researchers at Newcastle University have transformed global understanding, diagnosis, and treatment of the condition.

DLB gained public attention following the death of actor Robin Williams whose widow described his battle with the condition as “the terrorist inside my husband’s brain” highlighting the devastating toll the disease takes on individuals and their families. It is a complex and often misdiagnosed disease causing problems with understanding, thinking, memory and judgement as well as movement difficulties, visual hallucinations and sleep disturbances, placing a profound strain on patients and their families.

For over 30 years, researchers at Newcastle University have led the way in redefining DLB as a distinct and common cause of dementia. Their work has reshaped clinical practice worldwide, improving outcomes and offering hope to those affected.

Key breakthroughs include:

Identifying brain changes in relation to clinical symptoms that are related to DLB which helped establish international diagnostic guidelines. This was made possible by Newcastle University’s Brain Tissue Resource, which with over 2,200 donors is one of the UK’s largest brain donation programmes. Establishing dopamine-transporter (DAT) brain imaging as a diagnostic tool for DLB which is now recognised as the global gold-standard for accurate diagnosis. Linking biological changes to symptoms and progression, enabling earlier detection even before the dementia symptoms and more personalised care. Revolutionising treatment by discovering severe depletion of the brain chemical acetylcholine in DLB. This led to the first successful trials of therapies in DLB that restore its balance - now a global standard treatment that improves cognition and reduces hallucinations. Their research also exposed the risks of certain antipsychotic drugs, prompting safer prescribing practices worldwide. Today, Newcastle University continues to lead the field, exploring disease mechanisms, developing stem-cell models, and investigating blood-based tests and personalised therapies to detect and manage DLB earlier and more effectively.

This progress has been underpinned by the NIHR Newcastle Biomedical Research Centre and the Newcastle Health Research Partnership and been enabled by wide-ranging support from international and national funders along with industry partners.

Professor John-Paul Taylor, professor of Translational Dementia Research, Newcastle University said: “The Prize is recognition of the significant work and efforts of the Dementia with Lewy bodies team at Newcastle University over the past 30 years.

“Through close collaboration with patients, clinicians, and scientists across the globe, the University’s work has elevated DLB from an overlooked condition to a clearly defined, diagnosable, and increasingly treatable disease - setting new international standards for dementia care.

“We are building on this legacy with a vibrant multidisciplinary team that continues to strive to improve diagnosis and care of those affected.”

Professor Chris Day, Vice-Chancellor and President, Newcastle University, added: “This award is a great honour and a testament to the outstanding achievement of our team and the wider University community.

“Built on the visionary early work of scientific and clinical pioneers at Newcastle University, the Prize recognises more than three decades of ground-breaking research and unwavering dedication that have significantly advanced the diagnosis and care of individuals and families affected by Dementia with Lewy bodies.

“We are proud that our work is making a difference globally, and we remain committed to building on this world-leading research to further improve diagnosis, treatment, and ensuring healthier ageing for future generations.”

Run by the Royal Anniversary Trust, the Queen Elizabeth Prizes for Education celebrate excellence, innovation and public benefit in work carried out by UK colleges and universities.

Sir Damon Buffini, Chair of The Royal Anniversary Trust said: “The Queen Elizabeth Prizes for Higher and Further Education celebrate the power of education to change the world for the better. This much-loved national honour recognises, at the highest level of state, outstanding work in UK universities and colleges, and the remarkable benefit they bring to our economy, society and the wider world. This year we are delighted to honour 19 institutions whose work offers an inspiring snapshot of the excellent and innovative work going on in universities and colleges across the UK. Congratulations all!”

The Prime Minister, Sir Keir Starmer added: “This is a landmark year for the Prizes marking 30 years of recognising and celebrating the tremendous contribution our universities and colleges make to the life of our country.

“The UK has always been a place of learning, invention, and ambition. Our institutions of higher and further education are among the very best in the world. They educate the next generation, train our workforce, and lead the cutting-edge research that drives progress, not just here at home but across the world.”

This is the fifth time the University has been awarded what was previously known as the Queen’s Anniversary Prize, gaining the prize in 2023 for excellence in water research, in 2013 in recognition of its internationally renowned research into sustainable rural economies and societies. Newcastle received the prize in 2009 for research into ageing and again, in 2005 for its innovative solutions to mine water pollution.

Useful information:

Find out more about brain donation and the Newcastle University Brain Tissue Resource.

More information on research into dementia at Newcastle University  and the work of the Lewy Body Lab at Newcastle University.

Information on the DIAMOND-Lewy Programme – focused on improving diagnosis and management of Lewy body dementia across the NHS.

Find out how you can support research into Dementia with Lewy Bodies at Newcastle University

END


ELSE PRESS RELEASES FROM THIS DATE:

It’s a bird, it’s a drone, it’s both: AI tech monitors turkey behavior

2025-11-25
UNIVERSITY PARK, Pa. — At a time when millions of Americans have turkey on their minds, a team of researchers led by an animal scientist at Penn State has successfully tested a new way for poultry producers to keep their turkeys in sight.  Crucial for productivity and animal welfare, monitoring behavior and health of poultry animals on large, commercial farms is a costly, time-consuming and labor-intensive task. To help producers keep track of how the birds are behaving, the researchers tested a new method using a small drone equipped ...

Bormioli Luigi renews LionGlass deal with Penn State after successful trial run

2025-11-25
UNIVERSITY PARK, Pa. — Penn State’s LionGlass project has reached a major milestone in its partnership with Italian glassmaker Bormioli Luigi, marking one year of collaboration and the signing of a second-year agreement to continue commercialization efforts in the cosmetics packaging industry. The partnership, which began in 2024, aims to scale up LionGlass — a new family of glass developed at Penn State — as a sustainable alternative to traditional soda lime glass. LionGlass ...

Are developers prepared to control super-intelligent AI?

2025-11-25
UNIVERSITY PARK, Pa. — The dream of an artificial intelligence (AI)-integrated society could turn into a nightmare if safety is not prioritized by developers, according to Rui Zhang, assistant professor of computer science and engineering in the Penn State School of Electrical Engineering and Computer Science.  Zhang is the principal investigator on a project awarded $166,078 from Open Philanthropy to better mitigate sandbagging — attempting to look less capable or powerful — in AI models. While these systems go ...

A step toward practical photonic quantum neural networks

2025-11-25
Machine learning models called convolutional neural networks (CNNs) power technologies like image recognition and language translation. A quantum counterpart—known as a quantum convolutional neural network (QCNN)—could process information more efficiently by using quantum states instead of classical bits. Photons are fast, stable, and easy to manipulate on chips, making photonic systems a promising platform for QCNNs. However, photonic circuits typically behave linearly, limiting the flexible operations that neural networks need. In a study published ...

Study identifies target for disease hyper progression after immunotherapy in kidney cancer

2025-11-25
Researchers find that cancer cells mimic myeloid cells to hide from the immune system and promote disease hyper progression after immunotherapy Inhibiting the myeloid mimicry pathway along with immunotherapy improves antitumor outcomes in preclinical models Researchers at The University of Texas MD Anderson Cancer Center have found that renal medullary carcinoma (RMC) cells use an adaptive mechanism called “myeloid mimicry” to hide from the immune system and promote disease hyper progression after ...

Concordia researchers identify key marker linking coronary artery disease to cognitive decline

2025-11-25
Individuals with coronary artery disease (CAD) — a constricting or blocking of blood vessels feeding the heart — face increased risks of strokes, cognitive impairment and dementia. However, the link between CAD and cognitive function is not fully understood. A new study led by Concordia researchers looks at how the disease affects the brain’s white matter, the network of nerve fibers that connects different regions of the brains and is critical to transmitting information efficiently. The study, published in the journal Journal ...

HER2-targeted therapy shows promising results in rare bile duct cancers

2025-11-25
HER2-positive metastatic biliary tract cancer (BTC) is a rare and aggressive cancer with limited treatment options Final results from the HERIZON-BTC-01 clinical trial, the largest study of a HER2-targeted drug in BTC, show zanidatamab has clinically meaningful responses The targeted therapy demonstrated durable responses, longer survival and tumor shrinkage in some BTC patients Zanidatamab was granted accelerated FDA approval for treating HER2-positive BTC in Nov. 2024, based on these trial results Zanidatamab, a bispecific HER2-targeted antibody, delivered clinically meaningful and durable responses for patients with HER2-positive ...

Metabolic roots of memory loss

2025-11-25
For decades, scientists have known that what harms the body often harms the brain. Conditions such as obesity, high blood pressure and insulin resistance strain the body’s vascular and metabolic systems. Over time, that stress can speed up cognitive decline and increase the risk of Alzheimer’s disease. Now, researchers at Arizona State University and their collaborators report that these effects may begin far earlier than expected. In young adults with obesity, the team identified biological markers of inflammation, liver stress ...

Clinical outcomes and in-hospital mortality rate following heart valve replacements at a tertiary-care hospital

2025-11-25
Background and objectives Mechanical valve replacement is a primary treatment for rheumatic heart disease, yet prosthesis-related adverse outcomes remain underreported in India. This study aimed to examine the in-hospital mortality rate among patients who underwent prosthetic heart valve replacement surgeries in the past five years. Methods A retrospective analysis of 221 rheumatic heart disease patients (2019–2023) who underwent aortic valve replacement (AVR), mitral valve replacement (MVR), or double valve replacement (DVR) was conducted. Comorbidities (hypertension, type-2 diabetes mellitus) and valve origin (Indian ...

Too sick to socialize: How the brain and immune system promote staying in bed

2025-11-25
“I just can’t make it tonight. You have fun without me.” Across much of the animal kingdom, when infection strikes, social contact shuts down. A new study details how the immune and central nervous systems implement this sickness behavior. It makes perfect sense that when we’re battling an infection, we lose our desire to be around others. That protects them from getting sick and lets us get much needed rest. What hasn’t been as clear is how this behavior change happens. In the research published Nov. 25 in Cell, scientists at The Picower Institute for Learning and Memory of MIT and collaborators used multiple methods to demonstrate ...

LAST 30 PRESS RELEASES:

65-year-old framework challenged by modern research

AI tool helps visually impaired users ‘feel’ where objects are in real time

Collaborating minds think alike, processing information in similar ways in a shared task

Routine first trimester ultrasounds lead to earlier detection of fetal anomalies

Royal recognition for university’s dementia work

It’s a bird, it’s a drone, it’s both: AI tech monitors turkey behavior

Bormioli Luigi renews LionGlass deal with Penn State after successful trial run

Are developers prepared to control super-intelligent AI?

A step toward practical photonic quantum neural networks

Study identifies target for disease hyper progression after immunotherapy in kidney cancer

Concordia researchers identify key marker linking coronary artery disease to cognitive decline

HER2-targeted therapy shows promising results in rare bile duct cancers

Metabolic roots of memory loss

Clinical outcomes and in-hospital mortality rate following heart valve replacements at a tertiary-care hospital

Too sick to socialize: How the brain and immune system promote staying in bed

Seal milk more refined than breast milk

Veterans with cardiometabolic conditions face significant risk of dying during extreme heat events

How plants search for nutrients

Prefrontal cortex reaches back into the brain to shape how other regions function

Much-needed new drug approved for deadliest blood cancer

American College of Lifestyle Medicine publishes official position on lifestyle medicine as a framework for delivery of high-value, whole-person care

Hospital infections associated with higher risk of dementia

Thyroid dysfunction during pregnancy may increase autism risk in children

Cross-national willingness to share

Seeing rich people increases support for wealth redistribution

How personalized algorithms lead to a distorted view of reality

Most older drivers aren’t thinking about the road ahead, poll suggests

Earthquakes shake up Yellowstone’s subterranean ecosystems

Pusan National University study reveals a shared responsibility of both humans and AI in AI-caused harm

Nagoya Institute of Technology researchers propose novel BaTiO3-based catalyst for oxidative coupling of methane

[Press-News.org] Royal recognition for university’s dementia work
Newcastle University has won the UK’s highest national honor for universities in recognition of work transforming the understanding, diagnosis and care of people with dementia with Lewy bodies